US$ 29.83
epithalon tetrapeptide Research Grade Australia | AEDG Peptide Epithalon AEDG Research Peptide –
Description
Patients at this age have also been reported to have a high prevalence of vitamin B 12 deficiency, with estimates of up to 20% in the elderly

Vitamin B12 injections boost energy and promote healthy nerves and blood cells

It helps support the normal formation of red blood cells, healthy nerve function, and energy metabolism, making it an essential treatment for patients with confirmed B12 deficiency

With appropriate clinical trials, this gastric pentadecapeptide may ultimately provide clinically valuable applications for conditions currently lacking optimal treatment options
